SMOC-1 inhibitors belong to a distinctive class of chemical compounds that specifically target Secreted Modular Calcium-binding protein-1 (SMOC-1), a secreted extracellular matrix (ECM) protein involved in diverse cellular processes. SMOC-1 itself plays a crucial role in modulating cell adhesion, migration, and differentiation. The inhibitors designed for SMOC-1 exhibit a high degree of specificity, interfering with the activity of this protein in a selective manner. Structurally, these inhibitors often possess well-defined molecular features that enable them to interact with key binding sites on SMOC-1, disrupting its normal function.
SMOC-1 inhibitors is rooted in a deep understanding of the molecular interactions between SMOC-1 and its cellular partners. Researchers have meticulously designed these inhibitors to interact with specific regions of SMOC-1, blocking its activity without affecting other cellular processes. This precision in targeting is crucial for the potential modulation of cellular responses associated with SMOC-1. The inhibitors may act by preventing SMOC-1 from interacting with its natural ligands or by altering its conformation, thereby impeding its downstream signaling pathways.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Suramin sodium | 129-46-4 | sc-507209 sc-507209F sc-507209A sc-507209B sc-507209C sc-507209D sc-507209E | 50 mg 100 mg 250 mg 1 g 10 g 25 g 50 g | $152.00 $214.00 $728.00 $2601.00 $10965.00 $21838.00 $41096.00 | 5 | |
Suramin can interfere with growth factor signaling, potentially impacting angiogenesis where SMOC1 is implicated. | ||||||
Halofuginone | 55837-20-2 | sc-507290 | 100 mg | $1775.00 | ||
Halofuginone inhibits collagen type I synthesis and could affect tissue repair processes involving SMOC1. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor and may indirectly influence SMOC1-related pathways by altering cell survival and growth signals. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor which can impact inflammatory responses and possibly affect SMOC1's role in tissue repair. | ||||||
Thalidomide | 50-35-1 | sc-201445 sc-201445A | 100 mg 500 mg | $111.00 $357.00 | 8 | |
Affects angiogenesis and immune response modulation, which can influence the biological context of SMOC1. | ||||||
DAPT | 208255-80-5 | sc-201315 sc-201315A sc-201315B sc-201315C | 5 mg 25 mg 100 mg 1 g | $40.00 $120.00 $480.00 $2141.00 | 47 | |
Gamma-secretase inhibitor that can influence Notch signaling, potentially affecting processes where SMOC1 is active. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor that affects cell growth and may have an indirect effect on pathways where SMOC1 is involved. | ||||||
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | $26.00 $119.00 $213.00 | 27 | |
Inhibits BCR-ABL tyrosine kinase and could impact cellular processes related to SMOC1's function. | ||||||
Vismodegib | 879085-55-9 | sc-396759 sc-396759A | 10 mg 25 mg | $82.00 $158.00 | 1 | |
Hedgehog pathway inhibitor, which plays a role in various signaling pathways and might affect SMOC1's | ||||||